NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Rajratan Q2 FY27 PAT Rises 17% YoY to ₹24.14 Cr; Plans 50,000 TPA Thailand Expansion
Rajratan Global Wire reported a 26% YoY rise in consolidated revenue to ₹370.83 Cr for Q2 FY27, with sales volumes increasing 17% YoY to 38,605 MT. Profit after tax grew 17% YoY to ₹24.14 Cr, supported by a turnaround to profitability at the Chennai facility. EBITDA margin contracted by 125 bps YoY to 12.35% as the company prioritized volume growth and market share amid competitive and pricing pressures. Additionally, the company announced plans to expand its Thailand capacity by 50,000 TPA within one year to reach 1,10,000 TPA.
உச்சம் நம்பிக்கை
என்ன மாறியதுRajratan released its Q2 FY27 presentation detailing double-digit operational growth, Chennai plant turnaround, and an upcoming 50,000 TPA capacity expansion in Thailand.
ஏன் இது முக்கியம்Higher volumes and greenfield turnaround validate market share gains across India and Thailand, though gross margins reflect competitive trade-offs.
📅 குறுகிய காலம்Volume momentum and operational profitability at Chennai provide positive sentiment, balanced by margin compression from freight and competitive pricing.
📈 நீண்ட காலம்The planned scale-up to 1,10,000 TPA in Thailand and 60,000 TPA in Chennai strengthens Rajratan's moat as a premier low-cost, qualified bead wire supplier across Asian and Western export markets.
⚠ அபாய எச்சரிக்கைகள்
Margin contraction (-125 bps YoY) due to price-led volume chasing
Geopolitical shipping disruptions and freight volatility affecting export profitability
High dependence on cyclical automotive and tyre OEM demand
👀 கவனிக்க வேண்டியவை
Track the ramp-up and margin progression at the Chennai plant in Q3 FY27, along with execution timelines and capex commitments for the 50,000 TPA Thailand expansion.
J&K Bank Approves Q2 FY27 Financial Results; Reports Accounting Adjustments & Fund Tracking
The Jammu & Kashmir Bank Limited approved its integrated standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Auditors issued an unmodified review report while noting specific accounting impacts, including a ₹7.53 crore PAT gain for H1 FY27 from revising PSLC recognition to a systematic basis over the validity period. Additionally, ₹28.88 crore was credited to other income as prior period items relating to unlisted equity investments valued under FVTPL, and ₹263.63 crore was transferred from the Investment Fluctuation Reserve to General Reserve. The bank also reported zero deviation in the utilisation of earlier capital raises of ₹750 crore (QIP) and ₹274.75 crore (ESPS).
உச்சம் நம்பிக்கை
என்ன மாறியதுJ&K Bank announced its reviewed financial results for Q2 and H1 ended September 30, 2026, incorporating minor accounting modifications.
ஏன் இது முக்கியம்Clarifies statutory compliance, adjustments to reserve balances, and confirms full deployment of capital raised without deviations.
PSLC PAT Impact (H1): ₹7.53 கோடிFVTPL Gain in Other Income: ₹28.88 கோடிIFR to General Reserve Transfer: ₹263.63 கோடிQIP Fund Utilisation: Rs. 750 CroresESPS Fund Utilisation: Rs. 274.75 Crores
📅 குறுகிய காலம்Market reaction will depend primarily on the underlying headline Net Profit and NPA numbers relative to street estimates.
📈 நீண்ட காலம்Clean audit report and compliant capital allocation support steady execution against its target 50-50 geographical loan mix.
⚠ அபாய எச்சரிக்கைகள்
Prior period valuation adjustments contributing to other income rather than recurring operational lines.
👀 கவனிக்க வேண்டியவை
Track the detailed standalone headline metrics (NIM, gross/net NPA ratios, and core operating profit growth) when the complete balance sheet and investor presentation are reviewed.
J&K Bank Q2 FY27: NII Up 5% to ₹1,502 Cr; Gross NPA Hits Decadal Low of 2.23%
The Jammu & Kashmir Bank reported its Q2 FY27 results with Net Interest Income rising 5% YoY to ₹1,502 crore and Other Income doubling to ₹314.90 crore. Operating profit for the half year grew over 15% YoY to ₹1,492 crore, backed by strong cost control with the cost-to-income ratio improving to 56.57%. Asset quality showed significant improvement, reaching decadal bests with Gross NPA declining 109 bps YoY to 2.23% and Net NPA falling to 0.51%. Total business grew 19.38% YoY to ₹3,10,347 crore, driven by 23.72% growth in gross advances and a healthy CRAR of 16.57%.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe bank declared reviewed Q2 FY27 results showing double-digit credit expansion alongside a multi-year low in NPAs.
ஏன் இது முக்கியம்Demonstrates sustained operational turnaround and strengthening balance sheet buffers (CRAR 16.57%, PCR 91.76%) towards its Vision 2030 target of ₹5 lakh crore in business.
Net Interest Income (Q): Rs 1502 கோடிOther Income (Q): Rs 314.90 கோடிGross Advances: Rs 1,33,551 கோடிGross NPA: 2.23%நிகர NPA: 0.51%CRAR: 16.57%
📅 குறுகிய காலம்Earnings metrics show solid asset quality improvement and operating profit momentum, which should support sentiment in upcoming trading sessions.
📈 நீண்ட காலம்Progress towards loan book diversification beyond J&K and improving underwriting discipline support the bank's long-term business target of ₹5 lakh crore by 2030.
⚠ அபாய எச்சரிக்கைகள்
Geographic concentration risk in Jammu, Kashmir, and Ladakh region remains significant (~68% historically)
Accounting adjustments in PSLC income and prior-period fair value changes contributed to non-core income
👀 கவனிக்க வேண்டியவை
Track whether credit costs remain subdued and monitor whether the bank maintains its CASA ratio near ~42% amid expanding its loan book outside J&K.
HERC Grants 25-Year Electricity Distribution Licence to Consortium Involving HEC Infra Projects
The Haryana Electricity Regulatory Commission (HERC) has granted a 25-year electricity distribution licence to Eleven Power Private Limited, the lead member of a consortium that includes HEC Infra Projects Limited. The licence covers the Gurugram and Nuh revenue districts of Haryana. Under the consortium arrangement, HEC Infra's role will be to handle detailed engineering, execution, and maintenance of power distribution in these areas. Specific contract value and financial terms attributable to HEC Infra were not disclosed in the filing.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுA 25-year power distribution licence was granted by HERC to a consortium wherein HEC Infra Projects is a participating member.
ஏன் இது முக்கியம்Expands HEC Infra's presence in Haryana outside its home base of Gujarat, potentially securing long-term execution and maintenance revenue over a 25-year timeline.
📅 குறுகிய காலம்Positive sentiment driver for the stock as it validates geographic expansion, though immediate operational and cash flow impacts depend on upcoming project mobilization details.
📈 நீண்ட காலம்Provides long-term visibility for SITC and EPC maintenance work over a 25-year tenure in the high-demand Gurugram and Nuh circles.
⚠ அபாய எச்சரிக்கைகள்
Financial outlay, order value, and profit-sharing terms are not disclosed
Execution and regulatory risks associated with power distribution and local site delivery
👀 கவனிக்க வேண்டியவை
Track subsequent company disclosures regarding the exact contract value, revenue-sharing model, and capital expenditure obligations within the consortium.
Juniper Green Commissions 33 MW Wind Capacity; Total Operational Reaches ~2,844 MWp
Juniper Green Energy Limited's wholly owned subsidiary, Juniper Green Stellar Private Limited, has commissioned 33 MW of wind power capacity on October 21, 2026. This addition forms part of its 200 MW Firm and Dispatchable Renewable Energy (FDRE) project, bringing the project's commissioned capacity to 467.35 MWp and ~201 MWh BESS against a target of 550.6 MWp and ~201 MWh BESS. Following this commissioning, the group's aggregate operational capacity reached ~2,844 MWp alongside ~603 MWh BESS. The company reported quarterly revenues of Rs 291.20 crore in Jun 2026, and incremental operational capacity supports steady top-line growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுJuniper Green operationalized an additional 33 MW wind capacity as part of its ongoing FDRE project.
ஏன் இது முக்கியம்Increases overall operational capacity to ~2,844 MWp, driving incremental generation volumes and long-term cash flow visibility.
Capacity commissioned: 33 MWProject total planned capacity: 550.6 MWp and ~201 MWh BESSProject current capacity: 467.35 MWp and ~201 MWh BESSAggregate operational capacity: ~2,844 MWp and ~603 MWh BESSCommissioning date: அக்டோபர் 21, 2026
📅 குறுகிய காலம்Positive sentiment from continuous execution and progress on project commissioning timelines.
📈 நீண்ட காலம்Solidifies the company's dispatchable renewable energy footprint, supporting multi-year revenue compounding as BESS and hybrid portfolios expand.
⚠ அபாய எச்சரிக்கைகள்
Execution of remaining ~83.25 MWp project balance
Grid integration and resource availability (wind PLF variability)
👀 கவனிக்க வேண்டியவை
Track the commissioning of the remaining ~83.25 MWp to complete the 550.6 MWp FDRE project, and monitor how added capacity translates into revenue and PLF in upcoming quarterly results.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Jaykay Enterprises Subsidiary Secures CDSCO Manufacturing Licence for 8 Medical Implant Categories
Jaykay Enterprises' wholly owned subsidiary, JK Digital & Advance Systems Private Limited, has secured a lifetime manufacturing licence (Form MD-9) from CDSCO for Class C and Class D medical devices. The approval covers 8 categories of advanced orthopaedic and spinal implants made using titanium alloy powder (Ti6Al4V) under brand names Neobone and Nubone. The licence validates the company's diversification into additive manufacturing and specialized medical hardware alongside its core precision engineering base (TTM revenue of ₹259 Cr). No commercial sales volume or near-term revenue targets were quantified in the filing.
உச்சம் நம்பிக்கை
என்ன மாறியதுJK Digital & Advance Systems, a wholly owned subsidiary, received full regulatory approval to manufacture and sell Class C and Class D orthopaedic and spinal implants.
ஏன் இது முக்கியம்Enables commercialization of high-margin additive manufacturing capabilities in the healthcare sector, aiding revenue diversification beyond defence and IT.
Categories of medical implants approved: 8Licence validity: LifetimeLicence grant date: 21 அக்டோபர் 2026TTM Company Revenue: ₹259 கோடி
📅 குறுகிய காலம்Positive sentiment driver highlighting progress in high-tech manufacturing, though commercial revenue impact will take time to reflect in quarterly financials.
📈 நீண்ட காலம்Strengthens positioning in precision additive manufacturing for medical devices, potentially enhancing blended operating margins over the multi-year cycle.
⚠ அபாய எச்சரிக்கைகள்
Commercialization and hospital adoption lead times
Stringent post-market regulatory compliance and batch recall liabilities
👀 கவனிக்க வேண்டியவை
Track subsequent management commentary on the commercial launch timeline, hospital onboarding, and revenue contribution from the medical devices segment in upcoming quarterly earnings.
JTEKT India Approves 66.7% CVJ Capacity Expansion by 0.8 Million Units at Gujarat Plant
JTEKT India has approved a capacity expansion of 0.8 million units for its Constant Velocity Joint (CVJ) line at Jalisana, Gujarat. The existing capacity stands at approximately 1.2 million units and is running at ~90% utilization, representing a 66.7% capacity addition. The expansion is slated for completion by August 2028 and will be funded through a mix of internal accruals and debt. Capex investment amounts will be finalized and approved by the Board at a later stage.
உச்சம் நம்பிக்கை
என்ன மாறியதுJTEKT India has formally approved increasing its CVJ manufacturing capacity from 1.2 million to 2.0 million units at its Gujarat plant.
ஏன் இது முக்கியம்With current CVJ capacity operating at ~90%, this 66.7% expansion relieves bottlenecking and addresses rising driveline demand from passenger vehicle OEMs like Maruti Suzuki.
Existing Capacity: 1.2 Million (approx.)Capacity Addition: 0.8 Million (approx.)Current Capacity Utilization: 90% (approx.)Target Completion Date: ஆகஸ்ட் 2028Investment Required: வெளியிடப்படவில்லை
📅 குறுகிய காலம்Positive sentiment driver as the company signals strong visibility on OEM demand, though operational impact is distant.
📈 நீண்ட காலம்Expands the higher-value driveline product portfolio, diversifying revenue beyond core steering systems while serving major client ramps like Maruti Suzuki.
⚠ அபாய எச்சரிக்கைகள்
Long execution timeline extending to August 2028
Total capital expenditure outlay and borrowing quantum are yet to be disclosed
High exposure to passenger vehicle cyclicality (95% of revenue)
👀 கவனிக்க வேண்டியவை
Track subsequent board announcements regarding the final approved capex outlay and debt addition, alongside quarterly progress towards the August 2028 commissioning.
Jubilant Pharmova Seeks Shareholder Nod for up to ₹2,500 Cr NCD Issuance
Jubilant Pharmova has issued a Postal Ballot notice seeking shareholder approval to raise up to ₹2,500 crore via private placement of Non-Convertible Debentures (NCDs) within a one-year window. The proposed borrowing is within the company's existing overall borrowing limit of ₹5,000 crore. The funds are earmarked for capex, refinancing existing borrowings, working capital, and acquisitions. Remote e-voting runs from October 22, 2026 to November 20, 2026, with results expected by November 24, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has initiated shareholder voting via Postal Ballot to authorize an enabling resolution for raising up to ₹2,500 crore through NCDs.
ஏன் இது முக்கியம்The ₹2,500 crore authorization represents an enabling debt head-room (~29% of TTM revenue of ₹8,607 crore) to support potential capex, refinancing, and acquisitions without equity dilution.
Proposed NCD limit: ₹2,500 கோடிExisting overall borrowing limit: ₹5,000 கோடிNCD limit vs TTM revenue: ~29%NCD limit vs Net worth: ~108%E-voting cut-off date: அக்டோபர் 09, 2026
📅 குறுகிய காலம்Shareholders will vote on the enabling resolution through November 20, 2026. The announcement is procedural and unlikely to move the stock materially in the short term.
📈 நீண்ட காலம்If fully drawn, the debt could substantially increase leverage given current low debt of ₹53 crore, but it offers the company funding flexibility for organic capex and strategic acquisitions.
⚠ அபாய எச்சரிக்கைகள்
Potential increase in interest burden and leverage if large tranches are issued relative to net worth of ₹2,312 crore
Enabling resolution only; exact terms, pricing, and timing remain undetermined
👀 கவனிக்க வேண்டியவை
Track the outcome of the postal ballot voting by November 24, 2026, and watch for subsequent tranche-level debt issuance disclosures including coupon rates and tenure.
Digjam Limited announced its Q2 FY27 (quarter ended September 30, 2026) results alongside a change in its Registrar & Share Transfer Agent to MUFG Intime India. Revenue from operations dropped 29.8% YoY to ₹9.93 Cr (₹992.66 lakhs), though net profit from continuing operations rose to ₹1.40 Cr (₹139.58 lakhs) versus ₹0.86 Cr in the year-ago quarter. However, the statutory auditor highlighted material uncertainty regarding going concern, as current liabilities exceeded current assets by ₹19.72 Cr (₹1,971.80 lakhs) and Jamnagar manufacturing operations remain discontinued with assets held for sale worth ₹53.19 Cr. The company is actively banking on an ongoing Scheme of Arrangement with Reid & Taylor International.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved Q2 FY27 un-audited financial results and changed the RTA to MUFG Intime India Private Limited.
ஏன் இது முக்கியம்The company's core manufacturing operations remain shut with persistent liquidity deficits, making future viability heavily dependent on non-core asset sales and the Reid & Taylor merger.
Q2 FY27 Revenue from Operations: ₹9.93 கோடிQ2 FY27 PAT (Continuing Operations): ₹1.40 கோடிWorking Capital Deficit: ₹19.72 கோடிAssets Held for Sale: ₹53.19 கோடிTotal Borrowings (Current + Non-Current): ₹60.13 கோடி
📅 குறுகிய காலம்Market sentiment is likely to remain cautious due to the going-concern qualification and shrinking revenue base despite modest accounting profits.
📈 நீண்ட காலம்Long-term turnaround depends completely on the execution of the RTIL demerger/merger scheme and monetization of the Jamnagar manufacturing unit.
⚠ அபாய எச்சரிக்கைகள்
Material uncertainty on going concern raised by statutory auditor
Working capital deficit of ₹19.72 Cr with high leverage (Debt/Equity over 13x)
Core Jamnagar manufacturing facility discontinued since March 2025
👀 கவனிக்க வேண்டியவை
Track regulatory and court approvals regarding the proposed Scheme of Arrangement with Reid & Taylor International (appointed date July 1, 2025) and monitor progress on the disposal of the ₹53.19 Cr Jamnagar assets.
Jindal Photo Receives In-Principle Delisting Approval from BSE and NSE
Jindal Photo Limited has secured in-principle approval from both BSE and NSE on October 21, 2026, for the voluntary delisting of its equity shares under SEBI Delisting Regulations. The promoter group currently holds a 74.2% stake in the investment holding firm, which has a market cap of Rs 1,053 Cr. The company will now proceed toward reverse book building to discover the final exit price for public shareholders.
உச்சம் நம்பிக்கை
என்ன மாறியதுBSE and NSE have formally granted in-principle approvals for voluntary delisting, advancing the process to the public tendering stage.
ஏன் இது முக்கியம்A successful delisting will result in the stock being removed from exchanges, requiring public shareholders to either tender shares through the reverse book building mechanism or risk holding unlisted equity.
📅 குறுகிய காலம்Trading volume and price volatility may increase as the market prices in the potential delisting offer and reverse book building expectations.
📈 நீண்ட காலம்If delisting succeeds, the company will transition into a privately held Core Investment Company; if it fails, it remains listed subject to standard SEBI compliance.
⚠ அபாய எச்சரிக்கைகள்
Risk of delisting failure if required 90% threshold is not reached or if discovered price is rejected by promoters
Liquidity risk for shareholders holding unlisted shares if delisting succeeds
👀 கவனிக்க வேண்டியவை
Monitor upcoming disclosures for the floor price, reverse book building (bidding) dates, and the promoter's acceptance of the discovered delisting price.
PC Jeweller Turns Debt-Free in Q2 FY27; Operating PAT Rises 107% to ₹299 Cr, Sales Up 28%
PC Jeweller reported strong Q2 FY27 consolidated earnings, with revenue rising 28% YoY to ₹1,054 crore and operating PAT jumping 107% YoY to ₹299 crore. A crucial operational milestone was turning completely debt-free after discharging all outstanding dues to 14 consortium banks ahead of schedule. Additionally, the company realised ₹142 crore from long-pending export receivables. In the same meeting, the board noted nominal fines of ₹47,200 each imposed by BSE and NSE for a 2-day delay in applying for trading approval, which have already been paid.
உச்சம் நம்பிக்கை
என்ன மாறியதுPC Jeweller declared its Q2 FY27 results, achieved zero bank borrowings by clearing all consortium debt, and settled a nominal exchange compliance fine.
ஏன் இது முக்கியம்Eliminating bank debt removes substantial interest burdens and releases company and promoter guarantees, significantly de-risking the balance sheet as the business scales.
📅 குறுகிய காலம்Earnings growth and the official debt-free status are strong fundamental catalysts likely to be received positively by the market.
📈 நீண்ட காலம்Balance sheet clean-up and recovery of export dues pave the way for retail network expansion (targeting 100 showrooms) and asset-light franchise growth.
⚠ அபாய எச்சரிக்கைகள்
Gold price volatility
Execution risk on aggressive franchise and gold mining expansion plans in Chad
👀 கவனிக்க வேண்டியவை
Track the reduction in finance costs reflected in upcoming quarters following the debt payoff, and monitor progress on the planned rollout of up to 100 large-format showrooms over 12-18 months.
India Ratings Assigns IND AA+/Stable to Jubilant Pharmova's ₹1,400 Cr Proposed NCDs
India Ratings and Research has assigned an 'IND AA+/Stable' credit rating to Jubilant Pharmova Limited's proposed Non-Convertible Debentures (NCDs) amounting to ₹1,400.00 crore. The proposed borrowing is significant relative to the company's existing balance sheet, representing ~60.5% of its net worth (₹2,312 crore) and ~16.3% of TTM revenue (₹8,607 crore). This potential debt infusion will notably alter its current low-leverage profile, where existing debt stands at just ₹53 crore. Coupon rates, tenor, and specific issuance dates have not been disclosed in the rating letter.
உச்சம் நம்பிக்கை
என்ன மாறியதுIndia Ratings has formally assigned a high-grade credit rating ('IND AA+/Stable') for Jubilant Pharmova's proposed ₹1,400 crore NCD issuance.
ஏன் இது முக்கியம்Enables the company to access domestic debt markets at competitive borrowing costs, though executing the full issuance would significantly increase debt from the current ₹53 crore level.
Proposed NCD Amount: ₹1,400.00 கோடிCredit Rating Assigned: IND AA+/StableProposed NCD vs Net Worth: ~60.5%Proposed NCD vs TTM Revenue: ~16.3%
📅 குறுகிய காலம்Neutral to mildly positive tone given the strong credit rating (AA+), with market attention shifting to the final terms of issuance and pricing.
📈 நீண்ட காலம்If issued fully, the ₹1,400 crore debt will elevate leverage but likely support ongoing CDMO capacity ramp-ups and strategic expansions across North America and India.
⚠ அபாய எச்சரிக்கைகள்
Substantial increase in debt leverage if the full ₹1,400 crore is raised relative to current ₹53 crore debt.
Terms such as coupon rate, maturity, and specific utilization were not disclosed.
👀 கவனிக்க வேண்டியவை
Track subsequent board announcements regarding the actual issuance, coupon rate, and end-use of the ₹1,400 crore NCD proceeds (e.g., funding capex like Montreal/Spokane expansions vs. refinancing).
Bajaj Finance Limited has allotted 2,12,000 secured redeemable non-convertible debentures (NCDs) of face value Rs 1 lakh each, aggregating to Rs 2,120 crore on a private placement basis. The NCDs are zero coupon instruments with a tenure of 1,826 days (5 years), maturing on October 21, 2031. The issue constitutes approximately 2.06% of the company's net worth of Rs 1,03,123 crore and 2.46% of its TTM revenue of Rs 86,183 crore. The debentures will be listed on the Wholesale Debt Market segment of BSE Limited and are backed by a minimum 1.00x asset cover on book debts/loan receivables.
உச்சம் நம்பிக்கை
என்ன மாறியதுBajaj Finance completed the allotment of Rs 2,120 crore worth of 5-year zero-coupon secured NCDs to institutional investors on private placement.
ஏன் இது முக்கியம்Provides long-term wholesale funding to support routine balance sheet asset growth without creating immediate periodic interest payout burdens given the zero-coupon structure.
வெளியீட்டு அளவு: Rs 2,120 croreNumber of securities: 2,12,000Tenure: 1,826 DaysMaturity date: 21 அக்டோபர் 2031Issue size vs Net Worth: ~2.06%
📅 குறுகிய காலம்Neutral impact on stock price as private placement debt issuance is a routine business activity for large NBFCs.
📈 நீண்ட காலம்Limited structural significance; represents standard asset-liability management and ongoing funding of loan book expansion.
👀 கவனிக்க வேண்டியவை
Monitor quarterly borrowing costs and liability mix in the upcoming financial results to assess overall cost of funds management.
Bajaj Consumer Q2 Concall: Revenue at ₹233 Cr, Plans ~5% Effective Price Hike in Q3
Bajaj Consumer Care reported Q2 revenue of ₹233 crore (up 2.7% YoY) with an EBITDA of ₹53 crore and EBITDA margin of 25%. For H1, revenue rose 28% to ₹674 crore, while PAT jumped 75% to ₹141 crore. The flagship Almond Drops Hair Oil delivered double-digit unit volume growth, supported by smaller pack sizes. To combat raw material inflation from edible oils and crude, the company announced an upcoming ~5% effective price hike in Q3, split between price increases and pack size (ml-age) reductions.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript for the Q2 FY27 earnings conference call held on October 15, 2026.
ஏன் இது முக்கியம்Provides strategic commentary on passing through input cost inflation, progress in retail reach under Project Aarohan, and shifts toward third-party manufacturing.
📅 குறுகிய காலம்Earnings commentary confirms margin defense through a calibrated 5% price hike in Q3, though sequential top-line growth moderated to 2.7% YoY.
📈 நீண்ட காலம்Expansion through Aarohan 2.0 targeting double-digit direct reach increases and diversification outside ADHO remain central to sustaining 5-9% medium-term growth.
⚠ அபாய எச்சரிக்கைகள்
Raw material volatility in edible oils and crude derivatives
Consumer demand elasticity risk following the upcoming ~5% price and grammage intervention
👀 கவனிக்க வேண்டியவை
Track the impact of the planned ~5% Q3 price and grammage changes on unit volume growth and whether gross margins sustain around 60% amidst RM inflation.
Just Dial Q2 FY27: Revenue Up 13.1% YoY to ₹3,428 Mn; Net Profit at ₹1,078 Mn
Just Dial released its investor presentation for Q2 FY27 (ended September 30, 2026), reporting operating revenue of ₹3,428 million, up 13.1% YoY and 4.7% QoQ. Operating EBITDA reached ₹907 million compared to ₹871 million in Q2 FY26, while Net Profit stood at ₹1,078 million with a PAT margin of 27.1%. Paid campaigns expanded to 656,520, reflecting ongoing merchant adoption across 11,000+ pin codes. The company's treasury buffer remained robust with cash and investments increasing to ₹61,139 million.
உச்சம் நம்பிக்கை
என்ன மாறியதுJust Dial published its Q2 FY27 investor presentation showcasing steady revenue and campaign growth alongside quarterly financial metrics.
ஏன் இது முக்கியம்Provides granular operational health metrics, demonstrating solid SME monetisation, sustained double-digit top-line growth, and a fortress balance sheet.
📅 குறுகிய காலம்Stable operational performance and sequential top-line growth should support steady market sentiment.
📈 நீண்ட காலம்Strong cash generation, low leverage, and Reliance backing provide long-term resilience, though sustained re-rating depends on accelerating traffic growth and SME digital adoption.
⚠ அபாய எச்சரிக்கைகள்
Sequential decline in net profit (₹1,078 million vs ₹1,662 million in Q1 FY27)
Moderation in PAT margins from 36.2% in Q1 FY27 to 27.1% in Q2 FY27
👀 கவனிக்க வேண்டியவை
Track the trajectory of paid campaign additions and operating margin expansion amidst rising other expenses (12.7% of revenue). Also monitor capital deployment strategies given the sizable cash balance of ₹61,139 million.
Swaraj Suiting Details Rs 174.2 Cr Fundraise via Shares and Warrants at Rs 335/Share
Swaraj Suiting issued an EGM notice corrigendum detailing a combined preferential fundraise of Rs 174.20 crore, representing ~21.7% of its current market cap of Rs 801 crore. The fundraise comprises Rs 117.25 crore via equity shares and Rs 56.95 crore through 17,00,000 convertible warrants, both priced at Rs 335 per share/warrant. Proceeds from the equity issue are allocated primarily to working capital (Rs 88.25 crore), while the warrant proceeds will fund capital expenditure (Rs 30.00 crore) and working capital (Rs 14.95 crore). CRISIL Ratings Limited has been appointed as the monitoring agency.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company amended its EGM notice explanatory statements to detail specific utilization schedules, warrant conversion terms, and ultimate beneficial ownership of proposed allottees.
ஏன் இது முக்கியம்The capital injection of Rs 174.20 crore (~25.5% of TTM revenue) provides crucial liquidity to expand manufacturing capacity and support working capital for its growing denim business.
Total Preferential Fundraise: Rs 174.20 கோடிIssue Price per Share/Warrant: Rs 335Capex Allocation from Warrants: Rs 30.00 கோடிTotal Fundraise vs Market Cap: ~21.7%Total Fundraise vs TTM Revenue: ~25.5%
📅 குறுகிய காலம்Shareholders will vote on the preferential allotment proposals at the upcoming EGM scheduled for October 24, 2026.
📈 நீண்ட காலம்The Rs 30 crore capex and Rs 103.20 crore working capital infusion can significantly drive revenue scaling and improve operating leverage through March 2028-2029.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution from share issuance and conversion of 17,00,000 warrants
Warrant conversion proceeds depend on subscriber exercise within the 18-month window
👀 கவனிக்க வேண்டியவை
Track shareholder approval at the EGM on October 24, 2026, followed by the timeline for warrant allotment and receipt of funds.
JP Power Appoints New CFO, Company Secretary, and Independent Director
Jaiprakash Power Ventures Limited has approved key managerial appointments following its board meeting on October 19, 2026. Mr. Jigar Dalal has been appointed as the Chief Financial Officer effective November 1, 2026, while Mr. Paresh Patel takes over as Company Secretary and Compliance Officer effective December 1, 2026. Additionally, Mr. Ravi Kapoor has been appointed as an Independent Director for a 3-year term starting October 19, 2026, subject to shareholder approval. The filing also disclosed a settlement agreement with NARCL for Rs 511.00 crore, recognized as an exceptional item, and notes an unprovisioned lenders' recompense demand of Rs 5,69,651 lakhs (Rs 5,696.51 crore).
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reconstituted its key managerial personnel by appointing a new CFO and Company Secretary alongside a new Independent Director.
ஏன் இது முக்கியம்A transition in financial leadership is critical as the company navigates debt assignments, an exceptional Rs 511 crore NARCL settlement, and a disputed lenders' recompense claim of Rs 5,696.51 crore.
NARCL settlement provision: Rs 511.00 croresSettlement vs TTM revenue: ~8.9%Contested lender recompense claim: Rs 5,69,651 lakhsIndependent Director tenure: 3 consecutive years
📅 குறுகிய காலம்Limited direct share price reaction expected from the secretarial and CFO leadership changes, though the market may focus on the underlying exceptional settlement of Rs 511 crore.
📈 நீண்ட காலம்Strengthening financial governance under new leadership is essential given the company's legacy debt issues and ongoing legal disputes.
⚠ அபாய எச்சரிக்கைகள்
Unprovisioned recompense claim of Rs 5,69,651 lakhs by consortium lenders subject to auditor qualification
Execution risk on definitive agreements for the Rs 511 crore NARCL settlement
👀 கவனிக்க வேண்டியவை
Track the upcoming shareholder voting on the director appointment and monitor the final execution of the Rs 511.00 crore NARCL settlement agreement along with ongoing appeals regarding discom receivables.
JSW Dulux Receives GST Demand of ₹42.04 Cr, Reduced from Initial ₹118.33 Cr SCN
JSW Dulux Limited received an order dated 15th October 2026 from the Karnataka GST Department reducing its tax demand to ₹42.04 Cr from the initial Show Cause Notice demand of ₹118.33 Cr for the period April 2020 – March 2021. The confirmed demand includes ₹14.07 Cr in tax, ₹13.90 Cr in interest, and ₹14.07 Cr in penalty regarding input tax credit disallowance under Section 74. The revised demand equals approximately 1.2% of TTM revenue (₹3,577 Cr) and 52.8% of Jun 2026 quarterly PAT (₹79.7 Cr). The company stated it is in the process of responding and making further submissions to the relevant authorities.
உச்சம் நம்பிக்கை
என்ன மாறியதுKarnataka GST Department revised and issued an order confirming a demand of ₹42.04 Cr against an initial show cause notice of ₹118.33 Cr.
ஏன் இது முக்கியம்While substantially lower than the original notice, the demand represents over half of a standard quarterly net profit (Jun 2026 PAT: ₹79.7 Cr) if not successfully contested.
Final demand amount: Rs. 42,04,21,825Original SCN demand: Rs. 118,33,32,869Demand as % of Jun 2026 PAT: ~52.8%Demand as % of TTM revenue: ~1.2%
📅 குறுகிய காலம்Limited direct cash outflow immediately as the company intends to appeal; however, potential pre-deposit requirements could impact short-term cash flow.
📈 நீண்ட காலம்Limited; this is a one-off tax litigation from FY 2020-21 without operational impairment to ongoing business lines.
⚠ அபாய எச்சரிக்கைகள்
Risk of adverse appellate ruling requiring full payment or pre-deposit of ₹42.04 Cr
Potential penalty implications under Section 74 (fraud/willful misstatement allegations)
👀 கவனிக்க வேண்டியவை
Track subsequent legal appeals by the company and whether provisions or cash deposits are mandated during the appellate process.
Bajaj Finance Q2 FY27: PAT up 29% to ₹6,367 Cr; AUM expands 26% to ₹584,624 Cr
Bajaj Finance reported strong consolidated Q2 FY27 performance with PAT increasing 29% YoY to ₹6,367 crore and Net Interest Income rising 24% YoY to ₹13,335 crore. AUM grew 26% YoY to ₹584,624 crore, adding ₹37,680 crore during the quarter, supported by 13.45 million new loans booked. Asset quality improved as Gross NPA fell to 1.06% and Net NPA dropped to 0.42% (vs 0.60% a year ago). The Board also highlighted an upcoming capital raise of up to ₹17,500 crore (₹11,700 crore via QIP and ₹5,800 crore via promoter warrants), representing ~3.0% of current market cap.
உச்சம் நம்பிக்கை
என்ன மாறியதுBajaj Finance published its Q2 FY27 earnings presentation, showing 29% PAT growth, steady asset quality improvement, and reaffirmed plans for a ₹17,500 crore equity raise.
ஏன் இது முக்கியம்Demonstrates robust core operational momentum with 26% AUM expansion while maintaining stable margins and lower net credit costs, reinforcing its tier-1 retail franchise.
Consolidated PAT (Q2 FY27): ₹ 6,367 CrAUM: ₹ 584,624 croreGross NPA / Net NPA: 1.06% / 0.42%Approved Equity Raise: ₹ 17,500 croreFundraise vs Market Cap: ~3.0%
📅 குறுகிய காலம்Earnings show healthy balance sheet expansion and resilient margins, likely providing support following recent stock consolidation.
📈 நீண்ட காலம்Sustained high return ratios (ROE of 20.6%, ROA of 4.6%) and planned capital infusion position the company well to sustain 20%+ balance sheet growth.
⚠ அபாய எச்சரிக்கைகள்
Transitional surge in Stage 2 & 3 assets in the gold loan segment by ₹1,047 crore due to discontinued short-tenor schemes
Shareholder dilution from the proposed ₹17,500 crore QIP and preferential warrants
👀 கவனிக்க வேண்டியவை
Track shareholder approval and execution timelines for the ₹17,500 crore fundraise, along with credit cost trends in new verticals like gold loans and MFIs.
Bajaj Finance Q2 Standalone PAT Rises 30% YoY to ₹5,536.10 Cr
Bajaj Finance reported its standalone financial results for Q2 ended September 30, 2026, posting a 30.2% YoY rise in Profit After Tax to ₹5,536.10 crore compared to ₹4,250.77 crore in Q2 FY26. Standalone total income increased 23.0% YoY to ₹20,919.40 crore from ₹17,004.53 crore, driven by a 23.9% expansion in interest income to ₹18,549.14 crore. Finance costs rose 22.0% YoY to ₹6,398.84 crore, while impairment charges slightly increased to ₹2,130.51 crore from ₹2,036.77 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுBajaj Finance approved and disclosed its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
ஏன் இது முக்கியம்Demonstrates robust top-line momentum with 23% revenue growth and healthy profit expansion, keeping standalone earnings aligned with the company's long-term growth guidance.
Standalone PAT (Q2): ₹5,536.10 கோடிStandalone Total Income (Q2): ₹20,919.40 கோடிQ2 Standalone Revenue vs TTM Revenue: ~24.3%Impairment on Financial Instruments (Q2): ₹2,130.51 கோடிFinance Costs (Q2): ₹6,398.84 கோடி
📅 குறுகிய காலம்Earnings delivery aligns with strong seasonal performance, though market focus will remain on sequential credit costs and cost of funds.
📈 நீண்ட காலம்Solid underlying balance sheet expansion and steady interest income generation continue to support Bajaj Finance's targeted 24-26% medium-term growth trajectory.
⚠ அபாய எச்சரிக்கைகள்
Elevated finance costs up 22% YoY
Potential rise in credit costs and impairment charges in unsecured retail lending
👀 கவனிக்க வேண்டியவை
Track the management commentary on asset quality trends, rural segment credit costs, and the trajectory of net interest margins amid rising finance costs.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
